111 Inc
NASDAQ:YI
111 Inc
Gross Profit
111 Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
111 Inc
NASDAQ:YI
|
Gross Profit
¥849m
|
CAGR 3-Years
32%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
Gross Profit
¥8.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
LBX Pharmacy Chain JSC
SSE:603883
|
Gross Profit
¥7.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
Yunnan Jianzhijia Health-Chain Co Ltd
SSE:605266
|
Gross Profit
¥2.7B
|
CAGR 3-Years
30%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
Gross Profit
¥8.8B
|
CAGR 3-Years
19%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
Gross Profit
¥5.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
See Also
What is 111 Inc's Gross Profit?
Gross Profit
849m
CNY
Based on the financial report for Dec 31, 2023, 111 Inc's Gross Profit amounts to 849m CNY.
What is 111 Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
52%
Over the last year, the Gross Profit growth was 1%. The average annual Gross Profit growth rates for 111 Inc have been 32% over the past three years , 52% over the past five years .